,-1

Moayed Ibrahim1, Catherine Murphree1, Kirtesh Patel2

  • 1Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.

PubMed
概括

患有JAK2突变的骨髓增殖性瘤 (MPN) 患者在巨核细胞中增加了编程死亡连接体1 (PD-L1). 这表明,结合JAK2和检查点抑制剂可能是对JAK2突变MPN的可行的治疗方法.